Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Concord Health Partners is a venture capital firm specializing in healthcare investments, founded in 2017 and headquartered in Summit, New Jersey. The firm has established itself as a key player in the healthcare investment landscape, focusing on companies that develop innovative technologies and solutions aimed at enhancing healthcare delivery. Concord Health Partners has a total of $150 million in assets under management, primarily through its second fund, which closed in September 2022.
The firm has built a diverse portfolio of 15 companies, emphasizing operational efficiencies, improved patient outcomes, and expanded access to care. Notable milestones include the establishment of strategic partnerships with the American Hospital Association, which serves as an anchor limited partner in one of their funds. This relationship provides portfolio companies with valuable access to a broad network within the healthcare industry.
Concord Health Partners has also expanded its geographic footprint, with a Nashville office complementing its New Jersey headquarters. The firm’s commitment to driving growth and innovation in healthcare is evident in its investment strategy, which focuses on long-term partnerships with both limited partners and portfolio companies.
Concord Health Partners specializes in the healthcare sector, with a particular emphasis on Healthcare IT, Tech-Enabled Services, Healthcare Services, and Medical Technology. The firm seeks to invest in companies that demonstrate the potential to lower costs, improve quality, and expand access to care. Their investment strategy is characterized by a strong focus on behavioral health, as evidenced by their portfolio companies such as NeuroFlow and Learn to Live.
The firm typically engages in growth-stage investments, providing capital to companies that are poised for expansion. Check sizes vary, but they have led significant rounds, such as a $12.5 million investment in Loyal and a $40 million Series B round for Iris Telehealth. Concord Health Partners emphasizes building long-term strategic partnerships with both limited partners and portfolio companies, leveraging their extensive industry knowledge and relationships to create value.
Concord Health Partners looks for strong management teams that can drive innovation and operational efficiencies within their organizations. Their investment thesis is centered around technologies that enhance healthcare delivery, particularly in areas that address pressing needs in mental health and telemedicine.
Concord Health Partners has a diverse portfolio of 15 companies, each contributing to advancements in healthcare technology and services. Notable portfolio companies include:
This portfolio reflects Concord Health Partners' commitment to investing in technologies that improve healthcare delivery, particularly in the realms of mental health and telemedicine.
James T. Olsen: Founder & Managing Partner. James has extensive experience in healthcare investment and has been instrumental in establishing Concord Health Partners. He focuses on strategic direction and investment decisions.
Benson Jose: Partner/COO/CFO. Benson oversees operations and financial management, bringing a wealth of experience in healthcare finance.
Brian Gragnolati: Executive Partner. Brian has a strong background in healthcare operations and strategy, contributing to the firm's investment decisions.
Joseph Swedish: Partner Emeritus. Joseph has held various leadership roles in healthcare organizations, providing valuable insights into the industry.
George Hoffmann: Principal. George focuses on sourcing and evaluating investment opportunities within the healthcare sector.
Nathan Goldstein: Operating Partner. Nathan brings operational expertise to portfolio companies, helping them scale effectively.
Doug Shaw: Operating Partner. Doug works closely with portfolio companies to enhance operational efficiencies.
Chris DeRienzo, MD, MPP: AHA Special Advisor. Chris provides insights from the perspective of the American Hospital Association, enhancing the firm's strategic partnerships.
Harsh Trivedi, MD: Operating Partner. Harsh offers clinical insights and expertise in behavioral health.
Bruce Lawrence: Senior Advisor. Bruce provides strategic guidance based on his extensive experience in healthcare.
Nick Patel, MD: Operating Partner. Nick focuses on clinical aspects of portfolio companies, ensuring alignment with healthcare standards.
Brian Belsky: Consultant. Brian offers consulting services to enhance the firm's investment strategies.
To pitch to Concord Health Partners, founders should send an email to info@concordhp.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. The firm appreciates clarity and detail in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, especially from trusted industry contacts or existing portfolio companies.
In September 2022, Concord Health Partners closed its second fund, the Concord Innovation Fund II, with $150 million in committed capital. This fund focuses on growth-stage investments in healthcare innovation.
Recently, Concord Health Partners has deployed over 50% of Fund II across six portfolio companies, including Clarify Health, Loyal, Iris Telehealth, Learn to Live, Accelus, and MindMaze.
In October 2020, the firm led a $12.5 million round for Loyal, a healthcare consumer engagement platform. Additionally, they co-led a $40 million Series B round for Iris Telehealth, a telepsychiatry platform.
Concord Health Partners has also been active in growth equity financing for Hicuity Health, a tele-ICU provider, and has announced investments in NeuroFlow, a behavioral health SaaS platform.
What are Concord Health Partners' investment criteria?
Concord Health Partners invests in healthcare technologies that demonstrate the potential to lower costs, improve quality, and expand access to care. They focus on growth-stage companies within sectors such as Healthcare IT, Tech-Enabled Services, Healthcare Services, and Medical Technology.
How can startups apply or pitch to Concord Health Partners?
Startups can pitch to Concord Health Partners by sending an email to info@concordhp.com. It is advisable to include a detailed deck outlining the business model, market opportunity, and team background.
What makes Concord Health Partners different from other investors?
Concord Health Partners distinguishes itself through its strategic partnerships, particularly with the American Hospital Association, which provides portfolio companies with access to a vast network in the healthcare industry. Their focus on behavioral health and telemedicine also sets them apart.
What is the geographic scope of Concord Health Partners' investments?
The firm primarily invests in North America, targeting companies that are innovating within the healthcare sector.
What is Concord Health Partners' post-investment involvement like?
Concord Health Partners actively engages with its portfolio companies, providing operational expertise, strategic guidance, and access to their extensive network within the healthcare industry.
What is the typical check size for investments made by Concord Health Partners?
While specific check sizes can vary, Concord Health Partners has led significant rounds, including a $12.5 million investment in Loyal and a $40 million Series B for Iris Telehealth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.